14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study
Virak Eng, Dysoley Lek, Sitha Sin, Lionel Brice Feufack-Donfack, Ágnes Orbán, Jeremy Salvador, Dynang Seng, S. Heng, Nimol Khim, Kieran Tebben, Claude Flamand, Cécile Sommen, Rob W. van der Pluijm, Michael White, Benoît Witkowski, David Serre, Jean Popovici
Topics & Concepts
PrimaquineMedicinePlasmodium vivaxOpen labelVivax malariaMalariaInternal medicinePlasmodium falciparumClinical trialImmunologyChloroquineMalaria Research and ControlVector-borne infectious diseasesCoccidia and coccidiosis research